Is It Time To Reconsider Danaher (DHR) After The Recent Share Price Slump
- For readers wondering whether Danaher stock is starting to look appealing again after a rough stretch, this article focuses squarely on what you are paying versus what you might be getting.
- After closing at US$161.91, the stock is down 5.4% over the past week, 18.3% over the past month, 29.7% year to date, and 16.9% over the last year. Those moves may catch the eye of investors watching for changing risk and return trade offs.
- Recent share price moves sit against a backdrop of ongoing coverage of Danaher as a large US life sciences and diagnostics group and continuing interest in how its portfolio positions it within healthcare and research tools. While short term headlines can add noise, they also prompt investors to reassess what a…
Source link
